Closed · HRSA-17-078 · CFDA 93.365 · Discretionary
Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program
Federal grant opportunity posted by Health Resources and Services Administration, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- February 9, 2017
- Close date
- 5
- Expected awards
The verdict
Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program is a closed discretionary listing from Health Resources and Services Administration that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,731 other opportunities from Health Resources and Services Administration.
- Varies
- award range
- Closed
- application status
- 5
- expected awards
- 93.365
- CFDA program
Archived opportunity record
Sickle Cell Disease Treatment Demonstration R… is closed (last close February 9, 2017). Check the agency catalog for replacement NOFOs. Health Resources and Services Administration still indexes 1,731 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed February 9, 2017
Est. Total Funding
$3,575,000
Expected Awards
5
Instrument
Cooperative Agreement
Description
This announcement solicits applications for the Sickle Cell Treatment Demonstration Regional Collaboratives Program. The purpose of this funding opportunity is to fund Regional Coordinating Centers (RCC) that will establish regional networks and provide leadership and support for regional and statewide activities that will develop and establish systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease, by: (1) increasing the number of providers treating individuals with sickle cell disease using the National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report;[1] (2) using telementoring, telemedicine[2] and other provider support strategies to increase the number of providers administering evidence-based sickle cell care; and 3) developing and implementing strategies to improve access to quality care with emphasis on individual and family engagement/partnership, adolescent transitions to adult life, and care in a medical home. [1] National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report can be found online. A quick guide of the recommendations can be found at: http://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/Evd-Bsd_SickleCellDis_Rep2014.pdf [2] According to the American Telemedicine Association, telemedicine is the use of medical information exchanged from one site to another via electronic communications to improve a patient’s clinical health status. Telemedicine includes a growing variety of applications and services using two-way video, email, smart phones, wireless tools and other forms of telecommunications technology. (http://www.americantelemed.org/main/about/telehealth-faqs- )
Catch-all / unrestricted eligibility mark · HRSA-17-078
Grants.gov marks Sickle Cell Disease Treatment Demonstration R… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Health Resources and Services Administration book (1,128 peers, 65% of 1,732).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Department of Health and Human Services, Health Resources and Services Administration eivy@hrsa.gov
More from Health Resources and Services Administration
What to do next
Sickle Cell Disease Treatment Demonstration R… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.365 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |